Suppression of post-angioplasty restenosis with an Akt1 siRNA-embedded coronary stent in a rabbit model
Introduction
Restenosis remains the most significant consequence of percutaneous transluminal angioplasty, despite efforts to address it both biologically and mechanically [1], [2]. Gene therapy has been attempted as a treatment option in terms of controlling gene expression in neighboring cells related to restenosis. Non-viral gene delivery has been considered safer than its viral counterpart. Strategies for enhancing non-viral gene delivery typically involve the complexation of plasmids with cationic polymers or lipids, which can self-assemble with DNA to form particles capable of being endocytosed by cells. Substrate-mediated delivery results in the immobilization of DNA complexed with the carrier onto the substrate. Immobilization on the target surface can enhance gene transfer by maintaining an elevated concentration of DNA within the cellular microenvironment via sustained release and by facilitating subsequent cellular internalization [3].
Polyethyleneimine (PEI) is a commonly used polymeric gene carrier possessing a high density of primary, secondary, and tertiary amino groups that can be protonated at different environmental pH levels. At physiological pH, polycation is very effective in binding to DNA and can mediate the transfection of eukaryotic cells. However, its relatively higher cytotoxicity hinders clinical application [4], [5], [6]. Disulfide cross-linked PEI (ssPEI) is preferred in the design and synthesis of biodegradable polymers for drug delivery. It was previously demonstrated that ssPEI has an efficient transfection property in the A10 vascular smooth muscle cell (VSMC) line derived from the thoracic aorta of embryonic rats. First, disulfide bonds are more hydrolytically stable than ester bonds in the extracellular environment, thus polycation with disulfide bonds can be used to prepare stable complexes with plasmid DNA. Second, disulfide bonds can be cleaved rapidly by glutathione and thioredoxin reductase in the cytoplasm [7], [8], [9]. As a result, DNA can be rapidly released from polyplexes in order to mediate efficient gene expression. In addition, cytotoxicity can be reduced by avoiding high charge density and long-term polymer accumulation.
Akt1 siRNA was delivered to the cells with enhanced proliferation for knocking down the Akt1 protein responsible for cellular proliferation at the mRNA level. It has been reported that the inhibition of Akt1 decreases the expression of caspase-8 in endothelial cells. Suppression of downstream Akt1 signaling proteins such as Fas ligand results in the stimulation of caspase activity and apoptosis in VSMCs. It has also been demonstrated that the specific inhibition of Akt1 protein expression results in the retardation of cell growth [10], [11], [12], [13], [14].
Hyaluronic acid (HA) is highly compatible with cells and the cellular matrix. It can be efficiently degraded using specific enzymes, such as hyaluronidase; furthermore, its degradation products could induce extracellular matrix production and the neo-formation of blood capillaries [15], [16], [17]. HA enhances proliferation and migration of endothelial cells at a later stage, whereas Akt1 siRNA delivered from nanoparticles can knock down the initial over-growth of VSMCs near the implanted stent. Here, Akt1 siRNA delivery was evaluated on an HA-coated surface, and the subsequent inhibition of Akt1 protein expression was also determined.
In this study, ssPEI was complexed with Akt1 siRNA (Akt1 siRNA/ssPEI nanoparticles [ASNs]) and immobilized on an HA-coated surface. The binding ability of the ASNs and the release of siRNA from the HA-coated surface were studied. The potential efficacy of ASNs was evaluated with the rat VSMC line. The suppression of the Akt1 protein and its downstream signaling proteins regulating the cellular proliferation after the treatment with ASNs was examined. ASNs were coated on an HA stent deployed in the balloon-injured external iliac artery in a rabbit in vivo. Finally, post-angioplasty restenosis was measured by micro-computed tomography (micro-CT) imaging.
Section snippets
Materials
Branched PEI (bPEI) 25K and linear PEI (lPEI) 25K were purchased from Sigma–Aldrich (St. Louis, USA). Plasmid gWiz-luc (Aldevron, USA) was transformed into the competent cells, Escherichia coli DH5α, using the heat shock method. gWiz-luc was then propagated in bacterial cultures grown in Luria-Bertani (LB) media (Becton Dickinson, USA) containing 100 μg/ml of kanamycin (Biosesang Inc., Korea), and extracted and purified using a mini DNA-spin kit (Intron Biotechnol Co., Korea). Akt1 siRNA and
Optimization of transfection efficiency with ssPEI
The ssPEI with different N/P ratios was complexed with luciferase pDNA and its transfection efficiency was compared with two positive controls of bPEI 25 kDa and lPEI 25 kDa. After 24 h of transfection, transgene expression was measured by luciferase assay (Fig. 1). Compared to other carriers, ssPEI exhibited higher gene transfection efficiency as well as increased gene expression with an increase in DNA concentration.
Cell attachment studies on HA-coated stents
A10 VSMC lines were used to study cell attachment on HA-coated stents. It was
Discussion
Substrate-mediated delivery enhances gene transfer by increasing the concentration of DNA in the cellular microenvironment. Immobilized complexes in a substrate-mediated fashion deliver therapeutic genes to primary cells with improved cellular viability and transfection efficiency, in comparison with bolus delivery. Maximal transfection from this approach requires the affinity of the DNA complex to the substrate that is sufficient for immobilization, but not so excessive that it limits cellular
Conclusion
VSMC proliferation over the stent was suppressed by the delivery of Akt1 siRNA complexed with an ssPEI carrier on an HA-coated stent surface. The surface-mediated delivery resulted in higher protein expression compared to the bolus-mediated delivery, which is a benefit of stent-mediated delivery. The ssPEI showed reduced toxicity and higher gene expression compared to its non-degradable counterparts. The Akt1 siRNA was successfully delivered, and Akt1 suppression at the mRNA and protein level
Acknowledgments
This work was financially supported by the Bio Imaging Research Center at GIST. IKP also acknowledges the financial support of the Regional Technology Innovation Program of the Ministry of Commerce, Industry, and Energy (Grant RT104-01-01); the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science, and Technology (2010-0002940); the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs,
References (23)
- et al.
Substrate-mediated DNA delivery: role of the cationic polymer structure and extent of modification
J Control Release
(2003) - et al.
Biodegradable branched poly(ethylenimine sulfide) for gene delivery
Biomaterials
(2010) - et al.
Aerosol delivery of spermine-based poly(amino ester)/Akt1 shRNA complexes for lung cancer gene therapy
Int J Pharm
(2011) - et al.
The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway
Biomaterials
(2009) - et al.
Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells
Int J Pharm
(2009) - et al.
Stability of water-soluble carbodiimides in aqueous solution
Anal Biochem
(1990) - et al.
Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia
Circulation
(1989) - et al.
Restenosis after coronary angioplasty: an overview
J Am Coll Cardiol
(1991) - et al.
Gene expression and internalization following vector adsorption to immobilized proteins: dependence on protein identity and density
J Gene Med
(2007) - et al.
Gene delivery through cell culture substrate adsorbed DNA complexes
Biotechnol Bioeng
(2005)